Pioneering diabetes therapy highlights value of re-training
A new, state-of-the-art immunotherapy has been trialled on sufferers of Type-1 diabetes – and has been proven to be safe. Tested on nearly 30 people in the UK, there were also suggestions that the therapy could slow down the progress of the disease.